Literature DB >> 11886515

Transcriptional repression of the microphthalmia gene in melanoma cells correlates with the unresponsiveness of target genes to ectopic microphthalmia-associated transcription factor.

J Vachtenheim1, H Novotna, G Ghanem.   

Abstract

In the melanocyte, expression of genes required for pigment formation is mediated by the microphthalmia transcription factor, which is also critical for the development and survival of normal melanocytes during embryogenesis. Here we show that the expression of the melanocyte-specific isoform of microphthalmia transcription factor is lost in a subset of human melanoma cell lines, accompanied by the repression of tyrosinase and tyrosinase-related proteins 1 and 2, the three transcriptional target genes for microphthalmia. After the forced expression of microphthalmia transcription factor in melanoma cells where the expression of endogenous microphthalmia gene was found to be extinguished, no restoration of the melanogenic phenotype occurred and the transcription of the three microphthalmia transcription factor target genes remained silent. The transcription activation domain of microphthalmia transcription factor, tested as a GAL-MITF fusion protein, remained fully functional in these cells, however, and ectopic microphthalmia transcription factor localized normally to the nucleus and bound to the tyrosinase initiator E-box in gel retardation assays. Thus, the block of differentiation in microphthalmia-transcription-factor-negative melanomas extended the transcriptional repression of the microphthalmia transcription factor gene alone, and endogenous promoters in these melanoma cells became no longer responsive to microphthalmia transcription factor when this was substituted exogenously. The data presented suggest that a specific nuclear context is required for the transcriptional activation of the melanocyte markers by the microphthalmia transcription factor in malignant melanocytes and this specificity is lost concomitantly with the transcriptional repression of microphthalmia transcription factor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11886515     DOI: 10.1046/j.0022-202x.2001.01563.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

Review 1.  MC1R, eumelanin and pheomelanin: their role in determining the susceptibility to skin cancer.

Authors:  Tahseen H Nasti; Laura Timares
Journal:  Photochem Photobiol       Date:  2014-11-07       Impact factor: 3.421

2.  High GILT Expression and an Active and Intact MHC Class II Antigen Presentation Pathway Are Associated with Improved Survival in Melanoma.

Authors:  Kenneth H Buetow; Lydia R Meador; Hari Menon; Yih-Kuang Lu; Jacob Brill; Haiyan Cui; Denise J Roe; David J DiCaudo; K Taraszka Hastings
Journal:  J Immunol       Date:  2019-10-07       Impact factor: 5.422

Review 3.  Tyrosinase related protein 1 (TYRP1/gp75) in human cutaneous melanoma.

Authors:  Ghanem Ghanem; Journé Fabrice
Journal:  Mol Oncol       Date:  2011-02-03       Impact factor: 6.603

Review 4.  Beyond MITF: Multiple transcription factors directly regulate the cellular phenotype in melanocytes and melanoma.

Authors:  Hannah E Seberg; Eric Van Otterloo; Robert A Cornell
Journal:  Pigment Cell Melanoma Res       Date:  2017-09       Impact factor: 4.693

5.  miR-148 regulates Mitf in melanoma cells.

Authors:  Benedikta S Haflidadóttir; Kristín Bergsteinsdóttir; Christian Praetorius; Eiríkur Steingrímsson
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

6.  Selective down-regulation of tyrosinase family gene TYRP1 by inhibition of the activity of melanocyte transcription factor, MITF.

Authors:  Dong Fang; Yoshiaki Tsuji; Vijayasaradhi Setaluri
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

7.  Functional analysis of a nonstop mutation in MITF gene identified in a patient with Waardenburg syndrome type 2.

Authors:  Jie Sun; Ziqi Hao; Hunjin Luo; Chufeng He; Lingyun Mei; Yalan Liu; Xueping Wang; Zhijie Niu; Hongsheng Chen; Jia-Da Li; Yong Feng
Journal:  J Hum Genet       Date:  2017-03-30       Impact factor: 3.172

8.  Wnt signaling pathway involvement in genotypic and phenotypic variations in Waardenburg syndrome type 2 with MITF mutations.

Authors:  Xue-Ping Wang; Ya-Lan Liu; Ling-Yun Mei; Chu-Feng He; Zhi-Jie Niu; Jie Sun; Yu-Lin Zhao; Yong Feng; Hua Zhang
Journal:  J Hum Genet       Date:  2018-03-12       Impact factor: 3.172

9.  MITF-independent pro-survival role of BRG1-containing SWI/SNF complex in melanoma cells.

Authors:  Lubica Ondrušová; Jiri Vachtenheim; Jiri Réda; Petra Záková; Kamila Benková
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

10.  The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcoma.

Authors:  K K C Li; J Goodall; C R Goding; S-K Liao; C-H Wang; Y-C Lin; H Hiraga; T Nojima; K Nagashima; K-L Schaefer; K A W Lee
Journal:  Br J Cancer       Date:  2003-09-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.